Considering the superexpression of vascular endothelial growth factor (VEGF) in endometriosis [39–42], 99mTc-labeled monoclonal anti-VEGF antibody (bevacizumab-99mTc) was used as a radiopharmaceutical for endometriosis imaging in an endometriotic rat model in 2015 [43]. This evidence concerns the gene VEGFA and endometriosis.